The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugs
S. Yazdani, N. De Maio, Y. Ding…·M. Schapira
The paper identifies two highly conserved druggable sites in the SARS-CoV-2 replication-transcription complex as potential targets for broad-spectrum antiviral drugs.